Logo image of 1RKLB.MI

ROCKET LAB USA INC (1RKLB.MI) Stock Fundamental Analysis

BIT:1RKLB - Euronext Milan - US7731221062 - Common Stock - Currency: EUR

21.94  -0.54 (-2.42%)

Fundamental Rating

3

1RKLB gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 43 industry peers in the Aerospace & Defense industry. 1RKLB scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. 1RKLB is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

1RKLB had negative earnings in the past year.
1RKLB had a negative operating cash flow in the past year.
In the past 5 years 1RKLB always reported negative net income.
In the past 5 years 1RKLB always reported negative operating cash flow.
1RKLB.MI Yearly Net Income VS EBIT VS OCF VS FCF1RKLB.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -50M -100M -150M

1.2 Ratios

1RKLB's Return On Assets of -16.06% is on the low side compared to the rest of the industry. 1RKLB is outperformed by 90.70% of its industry peers.
1RKLB has a worse Return On Equity (-49.73%) than 81.40% of its industry peers.
Industry RankSector Rank
ROA -16.06%
ROE -49.73%
ROIC N/A
ROA(3y)-16.4%
ROA(5y)-18.08%
ROE(3y)-34.28%
ROE(5y)-34.08%
ROIC(3y)N/A
ROIC(5y)N/A
1RKLB.MI Yearly ROA, ROE, ROIC1RKLB.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -10 -20 -30 -40 -50

1.3 Margins

The Gross Margin of 1RKLB (26.63%) is comparable to the rest of the industry.
The Profit Margin and Operating Margin are not available for 1RKLB so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 26.63%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
1RKLB.MI Yearly Profit, Operating, Gross Margins1RKLB.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -50 -100 -150

More info and screens

4

2. Health

2.1 Basic Checks

1RKLB does not have a ROIC to compare to the WACC, probably because it is not profitable.
1RKLB has more shares outstanding than it did 1 year ago.
1RKLB has more shares outstanding than it did 5 years ago.
1RKLB has a worse debt/assets ratio than last year.
1RKLB.MI Yearly Shares Outstanding1RKLB.MI Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
1RKLB.MI Yearly Total Debt VS Total Assets1RKLB.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

An Altman-Z score of 7.78 indicates that 1RKLB is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 7.78, 1RKLB belongs to the top of the industry, outperforming 95.35% of the companies in the same industry.
A Debt/Equity ratio of 1.06 is on the high side and indicates that 1RKLB has dependencies on debt financing.
1RKLB's Debt to Equity ratio of 1.06 is on the low side compared to the rest of the industry. 1RKLB is outperformed by 72.09% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.06
Debt/FCF N/A
Altman-Z 7.78
ROIC/WACCN/A
WACC10.09%
1RKLB.MI Yearly LT Debt VS Equity VS FCF1RKLB.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

1RKLB has a Current Ratio of 2.04. This indicates that 1RKLB is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 2.04, 1RKLB belongs to the best of the industry, outperforming 88.37% of the companies in the same industry.
1RKLB has a Quick Ratio of 1.69. This is a normal value and indicates that 1RKLB is financially healthy and should not expect problems in meeting its short term obligations.
With an excellent Quick ratio value of 1.69, 1RKLB belongs to the best of the industry, outperforming 90.70% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.04
Quick Ratio 1.69
1RKLB.MI Yearly Current Assets VS Current Liabilites1RKLB.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

7

3. Growth

3.1 Past

The earnings per share for 1RKLB have decreased by -8.11% in the last year.
The Revenue has grown by 78.34% in the past year. This is a very strong growth!
Measured over the past years, 1RKLB shows a very strong growth in Revenue. The Revenue has been growing by 55.23% on average per year.
EPS 1Y (TTM)-8.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-33.33%
Revenue 1Y (TTM)78.34%
Revenue growth 3Y91.41%
Revenue growth 5Y55.23%
Sales Q2Q%32.13%

3.2 Future

Based on estimates for the next years, 1RKLB will show a very strong growth in Earnings Per Share. The EPS will grow by 41.09% on average per year.
Based on estimates for the next years, 1RKLB will show a very strong growth in Revenue. The Revenue will grow by 43.83% on average per year.
EPS Next Y-9.44%
EPS Next 2Y28.32%
EPS Next 3Y41.09%
EPS Next 5YN/A
Revenue Next Year33.13%
Revenue Next 2Y43.24%
Revenue Next 3Y41.27%
Revenue Next 5Y43.83%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
1RKLB.MI Yearly Revenue VS Estimates1RKLB.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B
1RKLB.MI Yearly EPS VS Estimates1RKLB.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 -0.4

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for 1RKLB. In the last year negative earnings were reported.
Also next year 1RKLB is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
1RKLB.MI Price Earnings VS Forward Price Earnings1RKLB.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -50 -100 -150

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
1RKLB.MI Per share data1RKLB.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 0.6 0.8

4.3 Compensation for Growth

A more expensive valuation may be justified as 1RKLB's earnings are expected to grow with 41.09% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y28.32%
EPS Next 3Y41.09%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for 1RKLB!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ROCKET LAB USA INC

BIT:1RKLB (5/23/2025, 7:00:00 PM)

21.94

-0.54 (-2.42%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)05-08 2025-05-08/amc
Earnings (Next)08-06 2025-08-06/amc
Inst Owners49.02%
Inst Owner ChangeN/A
Ins Owners0.64%
Ins Owner ChangeN/A
Market Cap10.12B
Analysts80
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)8.04%
Min EPS beat(2)3.88%
Max EPS beat(2)12.21%
EPS beat(4)4
Avg EPS beat(4)13.93%
Min EPS beat(4)3.88%
Max EPS beat(4)22.86%
EPS beat(8)6
Avg EPS beat(8)7.2%
EPS beat(12)8
Avg EPS beat(12)5.95%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.08%
Min Revenue beat(2)-0.61%
Max Revenue beat(2)0.46%
Revenue beat(4)1
Avg Revenue beat(4)-1.41%
Min Revenue beat(4)-4.26%
Max Revenue beat(4)0.46%
Revenue beat(8)2
Avg Revenue beat(8)-1.71%
Revenue beat(12)5
Avg Revenue beat(12)0.01%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 26.18
P/FCF N/A
P/OCF N/A
P/B 29.86
P/tB 45.18
EV/EBITDA N/A
EPS(TTM)-0.35
EYN/A
EPS(NY)-0.12
Fwd EYN/A
FCF(TTM)-0.22
FCFYN/A
OCF(TTM)-0.09
OCFYN/A
SpS0.84
BVpS0.73
TBVpS0.49
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -16.06%
ROE -49.73%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 26.63%
FCFM N/A
ROA(3y)-16.4%
ROA(5y)-18.08%
ROE(3y)-34.28%
ROE(5y)-34.08%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 1.06
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 199.36%
Cap/Sales 15.38%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.04
Quick Ratio 1.69
Altman-Z 7.78
F-Score5
WACC10.09%
ROIC/WACCN/A
Cap/Depr(3y)174.96%
Cap/Depr(5y)206.2%
Cap/Sales(3y)19.28%
Cap/Sales(5y)34.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-8.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-33.33%
EPS Next Y-9.44%
EPS Next 2Y28.32%
EPS Next 3Y41.09%
EPS Next 5YN/A
Revenue 1Y (TTM)78.34%
Revenue growth 3Y91.41%
Revenue growth 5Y55.23%
Sales Q2Q%32.13%
Revenue Next Year33.13%
Revenue Next 2Y43.24%
Revenue Next 3Y41.27%
Revenue Next 5Y43.83%
EBIT growth 1Y-6.68%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year61.27%
EBIT Next 3Y42.3%
EBIT Next 5YN/A
FCF growth 1Y24.48%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y50.55%
OCF growth 3YN/A
OCF growth 5YN/A